Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Infestation With Pediculus Humanus Capitis in the Community Using a leave-in Spray: A Prospective, Randomised Controlled Study

NCT05565820 is registered in ClinicalTrials.gov with Alliance Pharmaceuticals as lead sponsor.

NCT NCT05565820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05565820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Infestation With Pediculus Humanus Capitis in the Community Using a leave-in Spray: A Prospective, Randomised Controlled Study
Lead sponsor
Alliance Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
December 15, 2022
Completion date
March 12, 2023
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head lice, lice infestations, pediculosis capitis